USFDA

USFDA issues response letter for new drug application for insulin glargine: Biocon

Read more

USFDA pulls up Lantech Pharma for manufacturing violations at Andhra plant

Read more

Glenmark Pharma gets USFDA nod for skin treatment ointment

Read more

FDA gives fast track status to AstraZeneca’s diabetes drug Farxiga

Read more

Strides Pharma acquires USFDA approved manufacturing facility in US

Read more

USFDA clears Indoco’s Goa Plant II and III

Read more

Indoco Remedies gets warning letter from USFDA for oral dosages plant in Goa

Read more

USFDA inspection at Chennai facility ends with zero observations: Natco Pharma

Read more

USFDA issues 12 observations for three Biocon units in Malaysia

Read more

Alembic Pharma gets USFDA nod for seizure treatment drug

Read more